Correlation between cognitive functions and the PANSS cognitive factor in schizophrenic patients

被引：0
|
作者：
Rodriguez-Jimenez, R.
Martinez, I.
Jimenez-Arriero, M. A.
Ponce, G.
Bagney, A.
Aragues, M.
Koeneke, A.
Carretero, P.
Rubio, G.
Palomo, T.
机构：
[1] Univ Madrid, Hosp 12 Octubre, Dept Psychiat, Madrid 3, Spain
[2] Mental Hlth Serv, Retiro, Spain
来源：
EUROPEAN PSYCHIATRY | 2007年 / 22卷
关键词：
D O I：
10.1016/j.eurpsy.2007.01.435
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S135 / S136
页数：2
相关论文
共 50 条
  • [21] Cognitive therapy for schizophrenic patients
    Giebeler, U
    Brenner, HD
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2000, 68 : S50 - S54
  • [22] Correlation between insight dimensions and cognitive functions in patients with deficit and nondeficit schizophrenia
    Pegoraro, Luiz F. L.
    Dantas, Clarissa R.
    Banzato, Claudio E. M.
    Fuentes, Daniel
    SCHIZOPHRENIA RESEARCH, 2013, 147 (01) : 91 - 94
  • [23] The correlation between cognitive functions and serum uric acid levels in patients with schizophrenia
    Pradyumna
    Madhusudhan, S.
    INDIAN JOURNAL OF PSYCHIATRY, 2024, 66 : S58 - S59
  • [24] Cognitive deficits and cognitive training in schizophrenic patients: a review
    Rund, BR
    Borg, NE
    ACTA PSYCHIATRICA SCANDINAVICA, 1999, 100 (02) : 85 - 95
  • [25] Can the PANSS cognitive factor be a valid surrogate for neurocognition in schizophrenia?
    Sethuraman, G
    Ahmed, S
    Rock, SL
    Young, CA
    Marquez, EM
    Purdon, SE
    Keefe, RSE
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S292 - S293
  • [26] Absence of Ketamine effects on memory and other cognitive functions in schizophrenic patients
    LaPorte, DJ
    Lahti, AC
    Koffel, B
    Tamminga, CA
    JOURNAL OF PSYCHIATRIC RESEARCH, 1996, 30 (05) : 321 - 330
  • [27] Can the panss cognitive factor be a valid surrogate for neurocognition in schizophrenia?
    Sethuraman, G
    Ahmed, S
    Rock, SL
    Young, CA
    Marquez, EM
    Purdon, SE
    Keefe, RS
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S226 - S226
  • [28] Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin
    Ehrenreich, H.
    Hinze-Selch, D.
    Stawicki, S.
    Aust, C.
    Knolle-Veentjer, S.
    Wilms, S.
    Heinz, G.
    Erdag, S.
    Jahn, H.
    Degner, D.
    Ritzen, M.
    Mohr, A.
    Wagner, M.
    Schneider, U.
    Bohn, M.
    Huber, M.
    Czernik, A.
    Pollmaecher, T.
    Maier, W.
    Siren, A. -L.
    Klosterkoetter, J.
    Falkai, P.
    Ruether, E.
    Aldenhoff, J. B.
    Krampe, H.
    MOLECULAR PSYCHIATRY, 2007, 12 (02) : 206 - 220
  • [29] Executive/attentional cognitive functions in schizophrenic patients and their parents:: a preliminary study
    Dollfus, S
    Lombardo, C
    Bénali, K
    Halbecq, I
    Abadie, P
    Marié, RM
    Brazo, P
    SCHIZOPHRENIA RESEARCH, 2002, 53 (1-2) : 93 - 99
  • [30] Effects of cortisol infusion on cognitive functions in schizophrenic patients and healthy controls
    Ganguli, R
    Brar, JS
    Kathiresan, SM
    Vemulapalli, HK
    Fleischer, A
    Onarato, M
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 292 - 292
12345